159 related articles for article (PubMed ID: 36951508)
1. Continuity of care and advanced prostate cancer.
Jayadevappa R; Guzzo T; Vapiwala N; Malkowicz SB; Gallo JJ; Chhatre S
Cancer Med; 2023 May; 12(10):11795-11805. PubMed ID: 36951508
[TBL] [Abstract][Full Text] [Related]
2. Continuity of care in acute survivorship phase, and short and long-term outcomes in prostate cancer patients.
Chhatre S; Malkowicz SB; Jayadevappa R
Prostate; 2021 Dec; 81(16):1310-1319. PubMed ID: 34516667
[TBL] [Abstract][Full Text] [Related]
3. Association between hospital competition and quality of prostate cancer care.
Jayadevappa R; Malkowicz SB; Vapiwala N; Guzzo TJ; Chhatre S
BMC Health Serv Res; 2023 Aug; 23(1):828. PubMed ID: 37543580
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
5. Variation in quality of care among older men with localized prostate cancer.
Jayadevappa R; Chhatre S; Johnson JC; Malkowicz SB
Cancer; 2011 Jun; 117(11):2520-9. PubMed ID: 24048800
[TBL] [Abstract][Full Text] [Related]
6. The burden of depression in prostate cancer.
Jayadevappa R; Malkowicz SB; Chhatre S; Johnson JC; Gallo JJ
Psychooncology; 2012 Dec; 21(12):1338-45. PubMed ID: 21837637
[TBL] [Abstract][Full Text] [Related]
7. Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.
Amjad H; Carmichael D; Austin AM; Chang CH; Bynum JP
JAMA Intern Med; 2016 Sep; 176(9):1371-8. PubMed ID: 27454945
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic variation in health resource use and cost for prostate cancer.
Jayadevappa R; Malkowicz SB; Chhatre S; Gallo J; Schwartz JS
BJU Int; 2010 Sep; 106(6):801-8. PubMed ID: 20151963
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of treatments for high-risk prostate cancer patients.
Jayadevappa R; Lee DI; Chhatre S; Guzzo TJ; Malkowicz SB
Urol Oncol; 2019 Sep; 37(9):574.e11-574.e18. PubMed ID: 31285113
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Contribution of Patient-Provider Communication and Cancer Diagnosis to Racial Disparities in End-of-Life Care Among Medicare Beneficiaries.
Samuel-Ryals CA; Mbah OM; Hinton SP; Cross SH; Reeve BB; Dusetzina SB
J Gen Intern Med; 2021 Nov; 36(11):3311-3320. PubMed ID: 33963508
[TBL] [Abstract][Full Text] [Related]
11. Continuity of care and the risk of preventable hospitalization in older adults.
Nyweide DJ; Anthony DL; Bynum JP; Strawderman RL; Weeks WB; Casalino LP; Fisher ES
JAMA Intern Med; 2013 Nov; 173(20):1879-85. PubMed ID: 24043127
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
13. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
[TBL] [Abstract][Full Text] [Related]
14. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
[TBL] [Abstract][Full Text] [Related]
15. Association between Continuity and Team-Based Care and Health Care Utilization: An Observational Study of Medicare-Eligible Veterans in VA Patient Aligned Care Team.
Reddy A; Wong E; Canamucio A; Nelson K; Fihn SD; Yoon J; Werner RM
Health Serv Res; 2018 Dec; 53 Suppl 3(Suppl Suppl 3):5201-5218. PubMed ID: 30206936
[TBL] [Abstract][Full Text] [Related]
16. Primary care and specialty providers: an assessment of continuity of care, utilization, and expenditures.
Romaire MA; Haber SG; Wensky SG; McCall N
Med Care; 2014 Dec; 52(12):1042-9. PubMed ID: 25334053
[TBL] [Abstract][Full Text] [Related]
17. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
18. Primary care physician continuity, survival, and end-of-life care intensity.
Hung P; Cramer LD; Pollack CE; Gross CP; Wang SY
Health Serv Res; 2022 Aug; 57(4):853-862. PubMed ID: 34386976
[TBL] [Abstract][Full Text] [Related]
19. Substance use disorder and its effects on outcomes in men with advanced-stage prostate cancer.
Chhatre S; Metzger DS; Malkowicz SB; Woody G; Jayadevappa R
Cancer; 2014 Nov; 120(21):3338-45. PubMed ID: 25042396
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
